Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on December 17, 2007

Hypertension. 2007
Published online before print December 17, 2007, doi: 10.1161/HYPERTENSIONAHA.107.101717
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
51/2/521    most recent
HYPERTENSIONAHA.107.101717v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, L.
Right arrow Articles by Zucker, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, L.
Right arrow Articles by Zucker, I. H.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow ACE/Angiotension receptors

Submitted on September 23, 2007
Revised on October 13, 2007

Effects of Angiotensin Type 2 Receptor Overexpression in the Rostral Ventrolateral Medulla on Blood Pressure and Urine Excretion in Normal Rats

Lie Gao*; Weizhong Wang; Wei Wang; Hongwei Li; Colin Sumners; and Irving H. Zucker

From the Department of Cellular and Integrative Physiology (L.G., WeizhongW., WeiW., I.H.Z.), University of Nebraska Medical Center, Omaha; and the Department of Physiology and Functional Genomics (H.L., C.S.), University of Florida, Gainesville.

* To whom correspondence should be addressed. E-mail: lgao{at}unmc.edu.

Abstract—Central angiotensin II plays a critical role in the regulation of cardiovascular function and autonomic activity, in part, via angiotensin type 1 receptors in the rostral ventrolateral medulla (RVLM). Increasing evidence indicates that angiotensin II can also act on angiotensin type 2 receptors (AT2Rs) to exert antagonistic effects. In the current study we determined the effects of overexpression of AT2R in the RVLM on sodium and water excretion and on blood pressure in conscious rats. The overexpression of AT2R was induced by bilateral microinjection of the AT2R adenovirus (Ad5-SYN-AT2R-IRES-EGFP, 2.5x106 infection units in 0.5 µL; Ad5-SYN-EGFP as the control, 2.5x106 infection units in 0.5 µL) into the RVLM of rats. Immunofluorescence staining showed that microinjection of AT2R adenovirus into the RVLM evoked local overexpression. Significant overexpression of AT2R in the RVLM began at 24 hours and was sustained up to 12 days after microinjection. Overexpression of AT2R in the RVLM significantly decreased the nocturnal arterial blood pressure and increased the 24-hour urine excretion at days 2, 3, and 4 after gene delivery compared with the control rats. These alterations were abolished by the microinfusion of captopril into the RVLM and were enhanced by angiotensin II infusion. Overexpression of AT2R in the RVLM also significantly decreased the urine concentration of noradrenaline and 24-hour noradrenaline excretion (1.1±0.5 µg in control rats and 2.4±0.5 µg in AT2R rats; P<0.05). These results suggest that overexpression of AT2R in the RVLM induced a diuresis that may be mediated, in part, by sympathoinhibition.


Key words: angiotensin II type 2 receptor • rostral ventrolateral medulla • arterial blood pressure • urine excretion • noradrenaline excretion




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
R. D. Rudic and D. J. Fulton
Pressed for time: the circadian clock and hypertension
J Appl Physiol, October 1, 2009; 107(4): 1328 - 1338.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Mukaddam-Daher, A. Menaouar, P.-A. Paquette, M. Jankowski, J. Gutkowska, M.-A. Gillis, Y.-F. Shi, A. Calderone, and J.-C. Tardif
Hemodynamic and Cardiac Effects of Chronic Eprosartan and Moxonidine Therapy in Stroke-Prone Spontaneously Hypertensive Rats
Hypertension, May 1, 2009; 53(5): 775 - 781.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Xia, Y. Feng, T. D. Obr, P. J. Hickman, and E. Lazartigues
Angiotensin II Type 1 Receptor-Mediated Reduction of Angiotensin-Converting Enzyme 2 Activity in the Brain Impairs Baroreflex Function in Hypertensive Mice
Hypertension, February 1, 2009; 53(2): 210 - 216.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Gao, W.-Z. Wang, W. Wang, and I. H. Zucker
Imbalance of Angiotensin Type 1 Receptor and Angiotensin II Type 2 Receptor in the Rostral Ventrolateral Medulla: Potential Mechanism for Sympathetic Overactivity in Heart Failure
Hypertension, October 1, 2008; 52(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. H. Zucker
Angiotensin-Converting Enzyme 2: A New Player in Central Sympathetic Regulation?
Circ. Res., March 28, 2008; 102(6): 628 - 629.
[Full Text] [PDF]